Virtus ETF Advisers LLC Bei Gene, Ltd. Transaction History
Virtus ETF Advisers LLC
- $206 Million
- Q3 2024
A detailed history of Virtus ETF Advisers LLC transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 1,979 shares of BGNE stock, worth $371,062. This represents 0.22% of its overall portfolio holdings.
Number of Shares
1,979
Previous 1,979
-0.0%
Holding current value
$371,062
Previous $282,000
57.45%
% of portfolio
0.22%
Previous 0.14%
Shares
28 transactions
Others Institutions Holding BGNE
# of Institutions
252Shares Held
45.3MCall Options Held
292KPut Options Held
119K-
Baker Bros. Advisors LP New York, NY10.6MShares$1.98 Billion25.41% of portfolio
-
Capital International Investors Los Angeles, CA6.43MShares$1.21 Billion0.29% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.18MShares$971 Million26.65% of portfolio
-
Primecap Management CO Pasadena, CA4.97MShares$933 Million0.84% of portfolio
-
Baillie Gifford & CO3.71MShares$695 Million0.64% of portfolio
About BeiGene, Ltd.
- Ticker BGNE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,700,000
- Market Cap $19.4B
- Description
- BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...